Literature DB >> 4319937

Treatment of renal osteodystrophy with 25-hydroxycholecalciferol.

H F DeLuca, L V Avioli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4319937

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  6 in total

1.  Indications on the use of vitamin D and vitamin D metabolites in clinical phenotypes.

Authors:  M L Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2010-09

2.  Therapeutic and collateral effects of 25-hydroxycholecalciferol in vitamin D deficiency.

Authors:  M Moya; J Beltran; J Colomer
Journal:  Eur J Pediatr       Date:  1977-12-30       Impact factor: 3.183

3.  Treatment of uremic bone disease. Action of 5,6-trans-25-hydroxycholecalciferol (a vitamin D-analog) in chronic renal failure.

Authors:  D von Herrath; K Schaefer; D Kraft; H G Grigoleit; P Koeppe
Journal:  Klin Wochenschr       Date:  1973-10-01

4.  Plasma levels and therapeutic effect of 25-hydroxycholecalciferol in epileptic patients taking anticonvulsant drugs.

Authors:  T C Stamp; J M Round; D J Rowe; J G Haddad
Journal:  Br Med J       Date:  1972-10-07

Review 5.  Metabolism and action of the hormone vitamin D. Its relation to diseases of calcium homeostasis.

Authors:  J W Coburn; D L Hartenbower; A W Norman
Journal:  West J Med       Date:  1974-07

Review 6.  100 YEARS OF VITAMIN D: Historical aspects of vitamin D.

Authors:  Glenville Jones
Journal:  Endocr Connect       Date:  2022-04-22       Impact factor: 3.221
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.